SNRPD2-CPSF7-UBE2K axis drives ovarian cancer progression via alternative splicing-polyadenylation crosstalk. Li Y, Chen Z, Diao Y, Gao Q, et al. Oncogene 2026 May 7. doi: 10.1038/s41388-026-03812.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Li Y, Chen Z, Diao Y, Gao Q, et al. SNRPD2-CPSF7-UBE2K axis drives ovarian cancer progression via alternative splicing-polyadenylation crosstalk. Oncogene 2026 May 7. doi: 10.1038/s41388-026-03812.
PMID: 42098443